Medication Guide App

New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

August 2002

August 14

Lexapro (escitalopram oxalate) Tablets and Oral Solution

Date of Approval: August 14, 2002
Company: Forest Laboratories, Inc.
Treatment for: Depression, Generalized Anxiety Disorder

Lexapro (escitalopram oxalate) is a selective serotonin reuptake inhibitor (SSRI) indicated for the treatment of major depressive disorder and for the treatment of generalized anxiety disorder (GAD).

August 29

Lexapro (escitalopram oxalate)

New Indication Approved: August 29, 2002

December 2

Lexapro (escitalopram oxalate)

New Dosage Form Approved: November 27, 2002

December 18

Lexapro (escitalopram oxalate)

New Indication Approved: December 18, 2002

January 31

Eloxatin (oxaliplatin)

New Formulation Approved: January 31, 2005

March 20

Lexapro (escitalopram oxalate)

Patient Population Altered: March 20, 2009